Monitoring monocyte HLA-DR expression and CD4 + T lymphocyte count in dexamethasone-treated severe COVID-19 patients

Abstract Background A 10-day dexamethasone regimen has emerged as the internationally adopted standard-of-care for severe COVID-19 patients. However, the immune response triggered by SARS-CoV-2 infection remains a complex and dynamic phenomenon, leading to various immune profiles and trajectories. T...

Description complète

Détails bibliographiques

Auteurs principaux:	Guillaume Monneret, Nicolas Voirin, Jean-Christophe Richard, Martin Cour, Thomas Rimmelé, Lorna Garnier, Hodane Yonis, Remy Coudereau, Morgane Gossez, Christophe Malcus, Florent Wallet, Marie-Charlotte Delignette, Frederic Dailler, Marielle Buisson, Laurent Argaud, Anne-Claire Lukaszewicz, Fabienne Venet, for the RICO study group
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-05-01
Collection:	Annals of Intensive Care
Sujets:	Immunomonitoring Monocyte HLA-DR CD4 COVID-19 Dexamethasone
Accès en ligne:	https://doi.org/10.1186/s13613-024-01310-5
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!